Ledger.Open graph →
SEC Form D · filed September 11, 2015

Aclaris Therapeutics, Inc

Offering
$40.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MALVERN, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Kamil D. Ali-Jackson · Malvern, PAExecStuart D. Shanler · Malvern, PAExecFrank D. Ruffo · Malvern, PAExecStephen A. Tullman · Malvern, PADirectorChristopher Powala · Malvern, PAExecNeal Walker · Malvern, PAExec · DirectorChristopher A. Molineaux · Malvern, PADirectorKetan A. Patel · Malvern, PADirectorAnand A. Mehra · Malvern, PADirectorAlbert A. Cha · Malvern, PADirectorIndia GP LLC · Santa Monica, CAExecEden Shochat · San Francisco, CAExecStuart Browne · SCOTTSDALE, AZExecItai Danino · San Francisco, CAExec · DirectorDaniel G. Goldberg · New York, NYExec · DirectorJustin G. Gorenkoff · New York, NYExec · DirectorBill Mccullen · Boston, MADirectorLee Taylor · Boston, MAExecJonathan R. Baldwin · New York, NYExecChristopher A. Molineaux · Malvern, PADirectorKetan A. Patel · Malvern, PADirectorAnand A. Mehra · Malvern, PADirectorAlbert A. Cha · Malvern, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗